deferoxamine has been researched along with nitrous oxide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DeGraff, WG; Krishna, MC; Mitchell, JB; Russo, A | 1 |
| Bojadzic, D; Digruccio, MR; Leach, E; Lee, J; Nelson, MT; Orestes, P; Salajegheh, R; Todorovic, SM | 1 |
2 other study(ies) available for deferoxamine and nitrous oxide
| Article | Year |
|---|---|
Antimutagenicity of a low molecular weight superoxide dismutase mimic against oxidative mutagens.
Topics: Animals; Antimutagenic Agents; Carcinogenicity Tests; Catalase; CHO Cells; Cricetinae; Cyclic N-Oxides; Deferoxamine; Hydrogen Peroxide; Kinetics; Mutagenicity Tests; Nitrous Oxide; Regression Analysis; Spin Labels; Superoxide Dismutase; Superoxides; Xanthine Oxidase | 1992 |
Free radical signalling underlies inhibition of CaV3.2 T-type calcium channels by nitrous oxide in the pain pathway.
Topics: Adrenochrome; Analgesics, Non-Narcotic; Animals; Calcium Channel Blockers; Calcium Channels, T-Type; Catalase; Chelating Agents; Deferoxamine; Disease Models, Animal; Female; Ganglia, Spinal; HEK293 Cells; Histidine; Humans; Hydrogen Peroxide; Male; Membrane Potentials; Mice; Mice, Inbred C57BL; Mice, Knockout; Mutagenesis, Site-Directed; Nitrous Oxide; Organometallic Compounds; Oxidation-Reduction; Pain; Pentetic Acid; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Salicylates; Signal Transduction; Time Factors; Transfection | 2011 |